4.5 Regulation of disease-associated bacteria by metformin One study Forbes et al
By also mimicking glucagon, retatrutide may increase the likelihood of experiencing side effects compared to Mounjaro
The Food, Drug, and Cosmetics Act allows for compounding using bulk drug ingredients only if the drug is on the agency's 503B bulks list or the drug shortage list
Scientific References GLP-1 receptor agonists: reports of diabetic ketoacidosis when concomitant insulin was rapidly reduced or discontinued
Using health databases in Finland, Iceland, Norway, Sweden, the United States, and Israel, the researchers examined the outcomes of more than 3.5 million pregnancies between 2009 and 2021
Pfizer halted development of its oral GLP-1 danuglipron in 2025 after a trial participant developed liver injury, reflecting safety concerns that require ongoing monitoring with real-world data